Spitalul Clinic Judetean De Urgenta Sibiu
- Address
- Str. Pompeiu Onofreiu nr. 6, 557260 Sibiu, Romania
Spitalul Clinic Judetean De Urgenta Sibiu - Hematology Research
Spitalul Clinic Judetean De Urgenta Sibiu is an active clinical research center specializing in the investigation of hematological disorders. The center demonstrates particular expertise in studying autoimmune blood conditions, with a focus on developing novel therapeutic approaches for patients with rare and complex immune-mediated cytopenias.
- Primary Immune Thrombocytopenia (ITP) treatment optimization
- Advanced immunomodulatory therapies and disease control mechanisms
- Intravenous biologic agents for autoimmune hematologic conditions
The center's research program emphasizes rigorous evaluation of efgartigimod IV therapy and other innovative treatments for primary immune thrombocytopenia. Through participation in international clinical trials, the facility contributes to advancing understanding of disease control strategies and safety profiles of emerging biologic therapies in adult patients with ITP, supporting the development of more effective treatment options for this challenging autoimmune disorder.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Argenx1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Spitalul Clinic Judetean De Urgenta Sibiu
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Efgartigimod Alfa in Adults with Primary Immune Thrombocytopenia: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study | Argenx | Phase III | Recruiting | Feb 2025 | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Asciminib Hydrochloride | 1 | Unknown | 2022-11-21 | 2022-11-21 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.